{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T17:41:56Z","timestamp":1794246116786,"version":"4.9.0"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-74240-4","type":"journal-article","created":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T15:14:01Z","timestamp":1781277241000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Influence of protein aggregates, extracellular vesicles, and lipoprotein fusion on ionizable lipid nanoparticles protein corona analysis"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3193-0732","authenticated-orcid":false,"given":"Babak","family":"Borhan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-2124-351X","authenticated-orcid":false,"given":"Amanda M.","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2639-6328","authenticated-orcid":false,"given":"Amir Ata","family":"Saei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0126-334X","authenticated-orcid":false,"given":"Bahareh","family":"Ghaffari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4506-7415","authenticated-orcid":false,"given":"James E.","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-6680-1133","authenticated-orcid":false,"given":"Naseeha","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3628-2244","authenticated-orcid":false,"given":"Michael J.","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hojatollah","family":"Vali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0100-7824","authenticated-orcid":false,"given":"Kathryn A.","family":"Whitehead","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2575-9684","authenticated-orcid":false,"given":"Morteza","family":"Mahmoudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,12]]},"reference":[{"key":"74240_CR1","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/nrd4278","volume":"13","author":"U Sahin","year":"2014","unstructured":"Sahin, U., Karik\u00f3, K. & T\u00fcreci, \u00d6. mRNA-based therapeutics \u2014 developing a new class of drugs. Nat. Rev. Drug Discov. 13, 759\u2013780 (2014).","journal-title":"Nat. Rev. Drug Discov."},{"key":"74240_CR2","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/s41392-022-01007-w","volume":"7","author":"S Qin","year":"2022","unstructured":"Qin, S. et al. mRNA-based therapeutics: powerful and versatile tools to combat diseases. Signal Transduct. Target. Ther. 7, 166 (2022).","journal-title":"Signal Transduct. Target. Ther."},{"key":"74240_CR3","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1038\/s41573-021-00283-5","volume":"20","author":"N Chaudhary","year":"2021","unstructured":"Chaudhary, N., Weissman, D. & Whitehead, K. A. mRNA vaccines for infectious diseases: principles, delivery and clinical translation. Nat. Rev. Drug Discov. 20, 817\u2013838 (2021).","journal-title":"Nat. Rev. Drug Discov."},{"key":"74240_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-021-01348-0","volume":"20","author":"JD Beck","year":"2021","unstructured":"Beck, J. D. et al. mRNA therapeutics in cancer immunotherapy. Mol. cancer 20, 69 (2021).","journal-title":"Mol. cancer"},{"key":"74240_CR5","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.ymthe.2018.11.018","volume":"27","author":"A Magadum","year":"2019","unstructured":"Magadum, A., Kaur, K. & Zangi, L. mRNA-based protein replacement therapy for the heart. Mol. Ther. 27, 785\u2013793 (2019).","journal-title":"Mol. Ther."},{"key":"74240_CR6","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1136\/gutjnl-2019-318269","volume":"68","author":"P Berraondo","year":"2019","unstructured":"Berraondo, P., Martini, P. G., Avila, M. A. & Fontanellas, A. Messenger RNA therapy for rare genetic metabolic diseases. Gut 68, 1323\u20131330 (2019).","journal-title":"Gut"},{"key":"74240_CR7","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1089\/ten.tea.2017.0444","volume":"25","author":"S Patel","year":"2019","unstructured":"Patel, S. et al. Messenger RNA delivery for tissue engineering and regenerative medicine applications. Tissue Eng. Part A 25, 91\u2013112 (2019).","journal-title":"Tissue Eng. Part A"},{"key":"74240_CR8","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.jconrel.2010.01.036","volume":"145","author":"G Sahay","year":"2010","unstructured":"Sahay, G., Alakhova, D. Y. & Kabanov, A. V. Endocytosis of nanomedicines. J. Control Release 145, 182\u2013195 (2010).","journal-title":"J. Control Release"},{"key":"74240_CR9","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.addr.2019.08.004","volume":"144","author":"S Patel","year":"2019","unstructured":"Patel, S. et al. Brief update on endocytosis of nanomedicines. Adv. Drug Deliv. Rev. 144, 90\u2013111 (2019).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"74240_CR10","doi-asserted-by":"publisher","unstructured":"Wadhwa, A., Aljabbari, A., Lokras, A., Foged, C. & Thakur, A. Opportunities and challenges in the delivery of mRNA-based vaccines. Pharmaceutics 12, https:\/\/doi.org\/10.3390\/pharmaceutics12020102 (2020).","DOI":"10.3390\/pharmaceutics12020102"},{"key":"74240_CR11","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","volume":"6","author":"X Hou","year":"2021","unstructured":"Hou, X., Zaks, T., Langer, R. & Dong, Y. Lipid nanoparticles for mRNA delivery. Nat. Rev. Mater. 6, 1078\u20131094 (2021).","journal-title":"Nat. Rev. Mater."},{"key":"74240_CR12","doi-asserted-by":"publisher","first-page":"16982","DOI":"10.1021\/acsnano.1c04996","volume":"15","author":"R Tenchov","year":"2021","unstructured":"Tenchov, R., Bird, R., Curtze, A. E. & Zhou, Q. Lipid nanoparticles\u2500from liposomes to mrna vaccine delivery, a landscape of research diversity and advancement. ACS Nano 15, 16982\u201317015 (2021).","journal-title":"ACS Nano"},{"key":"74240_CR13","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/S0022-2836(65)80093-6","volume":"13","author":"AD Bangham","year":"1965","unstructured":"Bangham, A. D., Standish, M. M. & Watkins, J. C. Diffusion of univalent ions across the lamellae of swollen phospholipids. J. Mol. Biol. 13, 238\u2013252 (1965).","journal-title":"J. Mol. Biol."},{"key":"74240_CR14","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/s41573-024-00977-6","volume":"23","author":"PR Cullis","year":"2024","unstructured":"Cullis, P. R. & Felgner, P. L. The 60-year evolution of lipid nanoparticles for nucleic acid delivery. Nat. Rev. Drug Discov. 23, 709\u2013722 (2024).","journal-title":"Nat. Rev. Drug Discov."},{"key":"74240_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-27493-0","volume":"12","author":"X Han","year":"2021","unstructured":"Han, X. et al. An ionizable lipid toolbox for RNA delivery. Nat. Commun. 12, 7233 (2021).","journal-title":"Nat. Commun."},{"key":"74240_CR16","doi-asserted-by":"publisher","DOI":"10.1002\/smll.201805097","volume":"15","author":"KA Hajj","year":"2019","unstructured":"Hajj, K. A. et al. Branched-tail lipid nanoparticles potently deliver mRNA in vivo due to enhanced ionization at endosomal pH. Small 15, e1805097 (2019).","journal-title":"Small"},{"key":"74240_CR17","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1038\/s41565-023-01455-7","volume":"18","author":"H Tang","year":"2023","unstructured":"Tang, H. et al. Cholesterol modulates the physiological response to nanoparticles by changing the composition of protein corona. Nat. Nanotechnol. 18, 1067\u20131077 (2023).","journal-title":"Nat. Nanotechnol."},{"key":"74240_CR18","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.addr.2015.09.012","volume":"99","author":"JS Suk","year":"2016","unstructured":"Suk, J. S., Xu, Q., Kim, N., Hanes, J. & Ensign, L. M. PEGylation as a strategy for improving nanoparticle-based drug and gene delivery. Adv. Drug Deliv. Rev. 99, 28\u201351 (2016).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"74240_CR19","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/s41565-020-0669-6","volume":"15","author":"Q Cheng","year":"2020","unstructured":"Cheng, Q. et al. Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR-Cas gene editing. Nat. Nanotechnol. 15, 313\u2013320 (2020).","journal-title":"Nat. Nanotechnol."},{"key":"74240_CR20","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/j.jconrel.2022.03.046","volume":"345","author":"ST LoPresti","year":"2022","unstructured":"LoPresti, S. T., Arral, M. L., Chaudhary, N. & Whitehead, K. A. The replacement of helper lipids with charged alternatives in lipid nanoparticles facilitates targeted mRNA delivery to the spleen and lungs. J. Control Release 345, 819\u2013831 (2022).","journal-title":"J. Control Release"},{"key":"74240_CR21","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.ade1444","volume":"9","author":"JR Melamed","year":"2023","unstructured":"Melamed, J. R. et al. Ionizable lipid nanoparticles deliver mRNA to pancreatic \u03b2 cells via macrophage-mediated gene transfer. Sci. Adv. 9, eade1444 (2023).","journal-title":"Sci. Adv."},{"key":"74240_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2023.123695","volume":"650","author":"M Yang","year":"2024","unstructured":"Yang, M. et al. Effects of PEG antibodies on in vivo performance of LNP-mRNA vaccines. Int J. Pharm. 650, 123695 (2024).","journal-title":"Int J. Pharm."},{"key":"74240_CR23","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/j.jconrel.2024.04.022","volume":"370","author":"JB Simonsen","year":"2024","unstructured":"Simonsen, J. B. Lipid nanoparticle-based strategies for extrahepatic delivery of nucleic acid therapies - challenges and opportunities. J. Control Release 370, 763\u2013772 (2024).","journal-title":"J. Control Release"},{"key":"74240_CR24","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1038\/nnano.2012.207","volume":"7","author":"MP Monopoli","year":"2012","unstructured":"Monopoli, M. P., \u00c5berg, C., Salvati, A. & Dawson, K. A. Biomolecular coronas provide the biological identity of nanosized materials. Nat. Nanotechnol. 7, 779\u2013786 (2012).","journal-title":"Nat. Nanotechnol."},{"key":"74240_CR25","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1073\/pnas.0608582104","volume":"104","author":"T Cedervall","year":"2007","unstructured":"Cedervall, T. et al. Understanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles. Proc. Natl. Acad. Sci. USA 104, 2050\u20132055 (2007).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"74240_CR26","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1038\/nnano.2015.47","volume":"10","author":"PM Kelly","year":"2015","unstructured":"Kelly, P. M. et al. Mapping protein binding sites on the biomolecular corona of nanoparticles. Nat. Nanotechnol. 10, 472\u2013479 (2015).","journal-title":"Nat. Nanotechnol."},{"key":"74240_CR27","doi-asserted-by":"publisher","first-page":"5761","DOI":"10.1021\/ja910675v","volume":"132","author":"D Walczyk","year":"2010","unstructured":"Walczyk, D., Bombelli, F. B., Monopoli, M. P., Lynch, I. & Dawson, K. A. What the Cell \u201cSees\u201d in Bionanoscience. J. Am. Chem. Soc. 132, 5761\u20135768 (2010).","journal-title":"J. Am. Chem. Soc."},{"key":"74240_CR28","doi-asserted-by":"publisher","first-page":"11773","DOI":"10.1021\/acsnano.7b08008","volume":"11","author":"PC Ke","year":"2017","unstructured":"Ke, P. C., Lin, S., Parak, W. J., Davis, T. P. & Caruso, F. A decade of the protein corona. ACS Nano 11, 11773\u201311776 (2017).","journal-title":"ACS Nano"},{"key":"74240_CR29","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1038\/s41578-023-00552-2","volume":"8","author":"M Mahmoudi","year":"2023","unstructured":"Mahmoudi, M., Landry, M. P., Moore, A. & Coreas, R. The protein corona from nanomedicine to environmental science. Nat. Rev. Mater. 8, 422\u2013438 (2023).","journal-title":"Nat. Rev. Mater."},{"key":"74240_CR30","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/s41565-021-00860-0","volume":"16","author":"KA Dawson","year":"2021","unstructured":"Dawson, K. A. & Yan, Y. Current understanding of biological identity at the nanoscale and future prospects. Nat. Nanotechnol. 16, 229\u2013242 (2021).","journal-title":"Nat. Nanotechnol."},{"key":"74240_CR31","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/s41571-022-00645-x","volume":"19","author":"L Gardner","year":"2022","unstructured":"Gardner, L., Kostarelos, K., Mallick, P., Dive, C. & Hadjidemetriou, M. Nano-omics: nanotechnology-based multidimensional harvesting of the blood-circulating cancerome. Nat. Rev. Clin. Oncol. 19, 551\u2013561 (2022).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"74240_CR32","doi-asserted-by":"publisher","first-page":"8142","DOI":"10.1021\/acsnano.5b03300","volume":"9","author":"M Hadjidemetriou","year":"2015","unstructured":"Hadjidemetriou, M. et al. In vivo biomolecule corona around blood-circulating, clinically used and antibody-targeted lipid bilayer nanoscale vesicles. ACS nano 9, 8142\u20138156 (2015).","journal-title":"ACS nano"},{"key":"74240_CR33","doi-asserted-by":"publisher","DOI":"10.1002\/smll.201907574","volume":"16","author":"I Alberg","year":"2020","unstructured":"Alberg, I. et al. Polymeric nanoparticles with neglectable protein corona. Small 16, 1907574 (2020).","journal-title":"Small"},{"key":"74240_CR34","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1038\/nnano.2013.181","volume":"8","author":"S Tenzer","year":"2013","unstructured":"Tenzer, S. et al. Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology. Nat. Nanotechnol. 8, 772\u2013781 (2013).","journal-title":"Nat. Nanotechnol."},{"key":"74240_CR35","doi-asserted-by":"publisher","first-page":"3057","DOI":"10.1038\/s41596-025-01204-1","volume":"20","author":"H Tang","year":"2025","unstructured":"Tang, H., Wang, J. & Mahmoudi, M. Improving accuracy and reproducibility of mass spectrometry characterization of protein coronas on nanoparticles. Nat. Protoc. 20, 3057\u20133063 (2025).","journal-title":"Nat. Protoc."},{"key":"74240_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2022.114635","volume":"192","author":"W Kim","year":"2023","unstructured":"Kim, W. et al. Protein corona: Friend or foe? Co-opting serum proteins for nanoparticle delivery. Adv. Drug Deliv. Rev. 192, 114635 (2023).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"74240_CR37","doi-asserted-by":"publisher","first-page":"10025","DOI":"10.1021\/acs.nanolett.2c03741","volume":"22","author":"K Paunovska","year":"2022","unstructured":"Paunovska, K. et al. The extent to which lipid nanoparticles require apolipoprotein e and low-density lipoprotein receptor for delivery changes with ionizable lipid structure. Nano Lett. 22, 10025\u201310033 (2022).","journal-title":"Nano Lett."},{"key":"74240_CR38","doi-asserted-by":"crossref","unstructured":"Kim, M. et al. Engineered ionizable lipid nanoparticles for targeted delivery of RNA therapeutics into different types of cells in the liver. Sci. Adv. 7, eabf4398 (2021).","DOI":"10.1126\/sciadv.abf4398"},{"key":"74240_CR39","doi-asserted-by":"crossref","unstructured":"Dilliard, S.A., Cheng, Q. & Siegwart, D.J. On the mechanism of tissue-specific mRNA delivery by selective organ targeting nanoparticles. Proc. Natl. Acad. Sci. USA 118, e2109256118 (2021).","DOI":"10.1073\/pnas.2109256118"},{"key":"74240_CR40","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1161\/CIRCRESAHA.117.311767","volume":"121","author":"JB Simonsen","year":"2017","unstructured":"Simonsen, J. B. What are we looking at? Extracellular vesicles, lipoproteins, or both? Circulation Res. 121, 920\u2013922 (2017).","journal-title":"Circulation Res."},{"key":"74240_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-47724-4","volume":"15","author":"JB Simonsen","year":"2024","unstructured":"Simonsen, J. B. Technical challenges of studying the impact of plasma components on the efficacy of lipid nanoparticles for vaccine and therapeutic applications. Nat. Commun. 15, 3852 (2024).","journal-title":"Nat. Commun."},{"key":"74240_CR42","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202301838","volume":"19","author":"MJ Hajipour","year":"2023","unstructured":"Hajipour, M. J. et al. An overview of nanoparticle protein corona literature. Small 19, 2301838 (2023).","journal-title":"Small"},{"key":"74240_CR43","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2307803120","volume":"121","author":"V Francia","year":"2024","unstructured":"Francia, V. et al. A magnetic separation method for isolating and characterizing the biomolecular corona of lipid nanoparticles. Proc. Natl. Acad. Sci. USA 121, e2307803120 (2024).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"74240_CR44","doi-asserted-by":"publisher","first-page":"17802","DOI":"10.1021\/acsnano.2c08774","volume":"16","author":"R Tenchov","year":"2022","unstructured":"Tenchov, R. et al. Exosomes\u2500Nature\u2019s Lipid Nanoparticles, a Rising Star in Drug Delivery and Diagnostics. ACS Nano 16, 17802\u201317846 (2022).","journal-title":"ACS Nano"},{"key":"74240_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/srep27494","volume":"6","author":"JD Robertson","year":"2016","unstructured":"Robertson, J. D. et al. Purification of nanoparticles by size and shape. Sci. Rep. 6, 27494 (2016).","journal-title":"Sci. Rep."},{"key":"74240_CR46","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.70172","volume":"14","author":"R Ghebosu","year":"2025","unstructured":"Ghebosu, R. et al. Lipoprotein association fluorometry (laf) as a semi-quantitative characterization tool to assess extracellular vesicle-lipoprotein binding. J. Extracell. Vesicles 14, e70172 (2025).","journal-title":"J. Extracell. Vesicles"},{"key":"74240_CR47","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1038\/s41596-025-01229-6","volume":"21","author":"SA Sadeghi","year":"2026","unstructured":"Sadeghi, S. A. et al. Mass spectrometry-based top-down proteomics for proteoform profiling of protein coronas. Nat. Protoc. 21, 1092 (2026).","journal-title":"Nat. Protoc."},{"key":"74240_CR48","doi-asserted-by":"publisher","first-page":"12584","DOI":"10.1002\/anie.202004611","volume":"59","author":"JB Simonsen","year":"2020","unstructured":"Simonsen, J. B. & M\u00fcnter, R. Pay Attention to Biological Nanoparticles when Studying the Protein Corona on Nanomedicines. Angew. Chem. Int. Ed. 59, 12584\u201312588 (2020).","journal-title":"Angew. Chem. Int. Ed."},{"key":"74240_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-39768-9","volume":"14","author":"K Liu","year":"2023","unstructured":"Liu, K. et al. Multiomics analysis of naturally efficacious lipid nanoparticle coronas reveals high-density lipoprotein is necessary for their function. Nat. Commun. 14, 4007 (2023).","journal-title":"Nat. Commun."},{"key":"74240_CR50","doi-asserted-by":"publisher","first-page":"14695","DOI":"10.1021\/acs.nanolett.5c03793","volume":"25","author":"S Yoo","year":"2025","unstructured":"Yoo, S. et al. High-Throughput Formulation Using Fast mRNA Lipid Nanoparticle Assembly via Simple Thermomixing (HTF-FLASH). Nano Lett. 25, 14695\u201314703 (2025).","journal-title":"Nano Lett."},{"key":"74240_CR51","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1039\/D3NH00198A","volume":"8","author":"MFS Deuker","year":"2023","unstructured":"Deuker, M. F. S., Mail\u00e4nder, V., Morsbach, S. & Landfester, K. Anti-PEG antibodies enriched in the protein corona of PEGylated nanocarriers impact the cell uptake. Nanoscale Horiz. 8, 1377\u20131385 (2023).","journal-title":"Nanoscale Horiz."},{"key":"74240_CR52","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1038\/s41565-018-0246-4","volume":"13","author":"M Faria","year":"2018","unstructured":"Faria, M. et al. Minimum information reporting in bio-nano experimental literature. Nat. Nanotechnol. 13, 777\u2013785 (2018).","journal-title":"Nat. Nanotechnol."},{"key":"74240_CR53","doi-asserted-by":"publisher","first-page":"8858","DOI":"10.1039\/C7NR02977B","volume":"9","author":"M Kokkinopoulou","year":"2017","unstructured":"Kokkinopoulou, M., Simon, J., Landfester, K., Mail\u00e4nder, V. & Lieberwirth, I. Visualization of the protein corona: towards a biomolecular understanding of nanoparticle-cell-interactions. Nanoscale 9, 8858\u20138870 (2017).","journal-title":"Nanoscale"},{"key":"74240_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20884-9","volume":"12","author":"S Sheibani","year":"2021","unstructured":"Sheibani, S. et al. Nanoscale characterization of the biomolecular corona by cryo-electron microscopy, cryo-electron tomography, and image simulation. Nat. Commun. 12, 573 (2021).","journal-title":"Nat. Commun."},{"key":"74240_CR55","first-page":"695162","volume":"2025","author":"S Grumelot","year":"2025","unstructured":"Grumelot, S. et al. Lipid nanoparticle protein coronas form via lipoprotein fusion rather than shell-like adsorption. bioRxiv 2025, 695162 (2025).","journal-title":"bioRxiv"},{"key":"74240_CR56","doi-asserted-by":"publisher","first-page":"e0227949","DOI":"10.1371\/journal.pone.0227949","volume":"15","author":"A Emelyanov","year":"2020","unstructured":"Emelyanov, A. et al. Cryo-electron microscopy of extracellular vesicles from cerebrospinal fluid. PloS one 15, e0227949 (2020).","journal-title":"PloS one"},{"key":"74240_CR57","doi-asserted-by":"publisher","DOI":"10.3402\/jev.v2i0.21494","volume":"2","author":"Y Yuana","year":"2013","unstructured":"Yuana, Y. et al. Cryo-electron microscopy of extracellular vesicles in fresh plasma. J. Extracell. vesicles 2, 21494 (2013).","journal-title":"J. Extracell. vesicles"},{"key":"74240_CR58","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-67229-w","volume":"14","author":"A Parra","year":"2024","unstructured":"Parra, A. et al. Cryogenic electron microscopy reveals morphologically distinct subtypes of extracellular vesicles among porcine ejaculate fractions. Sci. Rep. 14, 16175 (2024).","journal-title":"Sci. Rep."},{"key":"74240_CR59","doi-asserted-by":"publisher","DOI":"10.3402\/jev.v5.31427","volume":"5","author":"A Milasan","year":"2016","unstructured":"Milasan, A. et al. Extracellular vesicles are present in mouse lymph and their level differs in atherosclerosis. J. Extracell. Vesicles 5, 31427 (2016).","journal-title":"J. Extracell. Vesicles"},{"key":"74240_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.hal.2023.102389","volume":"123","author":"MC Pernice","year":"2023","unstructured":"Pernice, M. C., Closa, D. & Garc\u00e9s, E. Cryo-electron microscopy of extracellular vesicles associated with the marine toxic dinoflagellate Alexandrium minutum. Harmful Algae 123, 102389 (2023).","journal-title":"Harmful Algae"},{"key":"74240_CR61","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1038\/s41565-023-01585-y","volume":"19","author":"R Liam-Or","year":"2024","unstructured":"Liam-Or, R. et al. Cellular uptake and in vivo distribution of mesenchymal-stem-cell-derived extracellular vesicles are protein corona dependent. Nat. Nanotechnol. 19, 846\u2013855 (2024).","journal-title":"Nat. Nanotechnol."},{"key":"74240_CR62","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1146\/annurev-biophys-090721-072718","volume":"51","author":"T Sych","year":"2022","unstructured":"Sych, T., Levental, K. R. & Sezgin, E. Lipid-protein interactions in plasma membrane organization and function. Annu Rev. Biophys. 51, 135\u2013156 (2022).","journal-title":"Annu Rev. Biophys."},{"key":"74240_CR63","doi-asserted-by":"publisher","first-page":"re14","DOI":"10.1126\/stke.3592006re14","volume":"2006","author":"MD Resh","year":"2006","unstructured":"Resh, M. D. Palmitoylation of ligands, receptors, and intracellular signaling molecules. Sci. STKE 2006, re14 (2006).","journal-title":"Sci. STKE"},{"key":"74240_CR64","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2021.659861","volume":"8","author":"C Busquets-Hern\u00e1ndez","year":"2021","unstructured":"Busquets-Hern\u00e1ndez, C. & Triola, G. Palmitoylation as a Key Regulator of Ras Localization and Function. Front Mol. Biosci. 8, 659861 (2021).","journal-title":"Front Mol. Biosci."},{"key":"74240_CR65","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1194\/jlr.R600004-JLR200","volume":"47","author":"LP Wright","year":"2006","unstructured":"Wright, L. P. & Philips, M. R. Thematic review series: lipid posttranslational modifications. CAAX modification and membrane targeting of Ras. J. Lipid Res. 47, 883\u2013891 (2006).","journal-title":"J. Lipid Res"},{"key":"74240_CR66","doi-asserted-by":"publisher","first-page":"3014","DOI":"10.1021\/bi00176a034","volume":"33","author":"JR Silvius","year":"1994","unstructured":"Silvius, J. R. & l\u2019Heureux, F. Fluorimetric evaluation of the affinities of isoprenylated peptides for lipid bilayers. Biochemistry 33, 3014\u20133022 (1994).","journal-title":"Biochemistry"},{"key":"74240_CR67","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1007\/s00249-003-0368-x","volume":"33","author":"AC Rowat","year":"2004","unstructured":"Rowat, A. C. et al. Farnesylated peptides in model membranes: a biophysical investigation. Eur. Biophys. J. 33, 300\u2013309 (2004).","journal-title":"Eur. Biophys. J."},{"key":"74240_CR68","doi-asserted-by":"crossref","unstructured":"Dalhaimer, P., Florey, B. & Isaac, S. Interactions of Apolipoproteins with Lipid-Based Nanoparticles. ACS Nano, 17, 837\u2013842 (2023).","DOI":"10.1021\/acsnano.2c10790"},{"key":"74240_CR69","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1039\/D0BM01609H","volume":"9","author":"R Zhang","year":"2021","unstructured":"Zhang, R. et al. Helper lipid structure influences protein adsorption and delivery of lipid nanoparticles to spleen and liver. Biomater. Sci. 9, 1449\u20131463 (2021).","journal-title":"Biomater. Sci."},{"key":"74240_CR70","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1021\/acs.nanolett.3c03579","volume":"24","author":"RE Ghebosu","year":"2024","unstructured":"Ghebosu, R. E., Pendiuk Goncalves, J. & Wolfram, J. Extracellular Vesicle and Lipoprotein Interactions. Nano Lett. 24, 1\u20138 (2024).","journal-title":"Nano Lett."},{"key":"74240_CR71","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12202","volume":"11","author":"S Busatto","year":"2022","unstructured":"Busatto, S. et al. Considerations for extracellular vesicle and lipoprotein interactions in cell culture assays. J. Extracell. Vesicles 11, e12202 (2022).","journal-title":"J. Extracell. Vesicles"},{"key":"74240_CR72","doi-asserted-by":"publisher","DOI":"10.1038\/mtna.2013.66","volume":"2","author":"BL Mui","year":"2013","unstructured":"Mui, B. L. et al. Influence of polyethylene glycol lipid desorption rates on pharmacokinetics and pharmacodynamics of sirna lipid nanoparticles. Mol. Ther. Nucleic Acids 2, e139 (2013).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"74240_CR73","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-63726-2","volume":"16","author":"E Voke","year":"2025","unstructured":"Voke, E. et al. Protein corona formed on lipid nanoparticles compromises delivery efficiency of mRNA cargo. Nat. Commun. 16, 8699 (2025).","journal-title":"Nat. Commun."},{"key":"74240_CR74","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/nmat2442","volume":"8","author":"AE Nel","year":"2009","unstructured":"Nel, A. E. et al. Understanding biophysicochemical interactions at the nano\u2013bio interface. Nat. Mater. 8, 543\u2013557 (2009).","journal-title":"Nat. Mater."},{"key":"74240_CR75","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23230-9","volume":"12","author":"MJ Hajipour","year":"2021","unstructured":"Hajipour, M. J. et al. Sex as an important factor in nanomedicine. Nat. Commun. 12, 2984 (2021).","journal-title":"Nat. Commun."},{"key":"74240_CR76","doi-asserted-by":"crossref","unstructured":"Lin, Z. et al. Sex influences the safety and therapeutic efficacy of cardiac nanomedicine technologies. Small, 20, e2305940 (2023).","DOI":"10.1002\/smll.202305940"},{"key":"74240_CR77","doi-asserted-by":"publisher","first-page":"2448","DOI":"10.1021\/acs.molpharmaceut.1c00291","volume":"18","author":"E Vulpis","year":"2021","unstructured":"Vulpis, E. et al. The possible role of sex as an important factor in development and administration of lipid nanomedicine-based COVID-19 vaccine. Mol. Pharmaceutics 18, 2448\u20132453 (2021).","journal-title":"Mol. Pharmaceutics"},{"key":"74240_CR78","doi-asserted-by":"publisher","DOI":"10.1016\/j.nantod.2022.101479","volume":"44","author":"SM Moghimi","year":"2022","unstructured":"Moghimi, S. M. & Simberg, D. Critical issues and pitfalls in serum and plasma handling for complement analysis in nanomedicine and bionanotechnology. Nano Today 44, 101479 (2022).","journal-title":"Nano Today"},{"key":"74240_CR79","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1038\/s41565-019-0591-y","volume":"14","author":"A Akinc","year":"2019","unstructured":"Akinc, A. et al. The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs. Nat. Nanotechnol. 14, 1084\u20131087 (2019).","journal-title":"Nat. Nanotechnol."},{"key":"74240_CR80","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-58523-w","volume":"16","author":"MHY Cheng","year":"2025","unstructured":"Cheng, M. H. Y. et al. Liposomal lipid nanoparticles for extrahepatic delivery of mRNA. Nat. Commun. 16, 4135 (2025).","journal-title":"Nat. Commun."},{"key":"74240_CR81","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2109256118","volume":"118","author":"SA Dilliard","year":"2021","unstructured":"Dilliard, S. A., Cheng, Q. & Siegwart, D. J. On the mechanism of tissue-specific mRNA delivery by selective organ targeting nanoparticles. Proc. Natl. Acad. Sci. USA 118, e2109256118 (2021).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"74240_CR82","unstructured":"Ghaffari, B. et al. Recalibrating Nanoparticle Protein Corona Analysis for Accurate Biological Identity and Soluble Plasma Proteome Profiling. bioRxiv, 2026.2002.2019.706828 (2026)."},{"key":"74240_CR83","doi-asserted-by":"publisher","first-page":"2525","DOI":"10.1021\/ja107583h","volume":"133","author":"MP Monopoli","year":"2011","unstructured":"Monopoli, M. P. et al. Physical\u2212chemical aspects of protein corona: relevance to in vitro and in vivo biological impacts of nanoparticles. J. Am. Chem. Soc. 133, 2525\u20132534 (2011).","journal-title":"J. Am. Chem. Soc."},{"key":"74240_CR84","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/nnano.2012.237","volume":"8","author":"A Salvati","year":"2013","unstructured":"Salvati, A. et al. Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface. Nat. Nanotechnol. 8, 137\u2013143 (2013).","journal-title":"Nat. Nanotechnol."},{"key":"74240_CR85","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.1021\/nn506060q","volume":"9","author":"S Wan","year":"2015","unstructured":"Wan, S. et al. The \u201cSweet\u201d side of the protein corona: effects of glycosylation on nanoparticle\u2013cell interactions. ACS Nano 9, 2157\u20132166 (2015).","journal-title":"ACS Nano"},{"key":"74240_CR86","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/nnano.2017.61","volume":"12","author":"M Hadjidemetriou","year":"2017","unstructured":"Hadjidemetriou, M. & Kostarelos, K. Evolution of the nanoparticle corona. Nat. Nanotechnol. 12, 288\u2013290 (2017).","journal-title":"Nat. Nanotechnol."}],"updated-by":[{"DOI":"10.1038\/s41467-026-77177-w","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000}}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-74240-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-74240-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-74240-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T23:05:01Z","timestamp":1792451101000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-74240-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,12]]},"references-count":86,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["74240"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-74240-4","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,12]]},"assertion":[{"value":"5 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"In the version of the article initially published, the peer review statement incorrectly said that a peer review file was available. The peer review statement has now been corrected in the HTML and PDF versions of the article.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2026","order":8,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":9,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41467-026-77177-w","URL":"https:\/\/doi.org\/10.1038\/s41467-026-77177-w","order":11,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.M. is co-founder and director of the Academic Parity Movement (\n                      \n                      ) (a non-profit organization dedicated to addressing academic discrimination, violence and incivility) and co-founder of Targets Tip, AlbuDerm, and XProteome Inc., and receives royalties\/honoraria for his published books, plenary lectures, and licensed patents. B.B. and A.A.S. are co-founders of XProteome. The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"5261"}}